These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Insulin analogues: place of detemir (levemir)]. Dorchy H; Sternon J Rev Med Brux; 2006; 27(2):89-94. PubMed ID: 16736846 [TBL] [Abstract][Full Text] [Related]
24. Insulin aspart: a review of its use in the management of type 1 and 2 diabetes mellitus. Chapman TM; Noble S; Goa KL Drugs; 2002; 62(13):1945-81. PubMed ID: 12215068 [TBL] [Abstract][Full Text] [Related]
25. Treatment of diabetes mellitus using an external insulin pump in clinical practice. Jeandidier N; Riveline JP; Tubiana-Rufi N; Vambergue A; Catargi B; Melki V; Charpentier G; Guerci B Diabetes Metab; 2008 Sep; 34(4 Pt 2):425-38. PubMed ID: 18951117 [TBL] [Abstract][Full Text] [Related]
26. Subcutaneous injection of hyaluronidase with recombinant human insulin compared with insulin lispro in type 1 diabetes. Garg SK; Buse JB; Skyler JS; Vaughn DE; Muchmore DB Diabetes Obes Metab; 2014 Nov; 16(11):1065-9. PubMed ID: 24840317 [TBL] [Abstract][Full Text] [Related]
27. Continuous subcutaneous insulin infusion (CSII) pumps. Valla V Adv Exp Med Biol; 2012; 771():414-9. PubMed ID: 23393693 [TBL] [Abstract][Full Text] [Related]
28. Insulin lispro: its role in the treatment of diabetes mellitus. Campbell RK; Campbell LK; White JR Ann Pharmacother; 1996 Nov; 30(11):1263-71. PubMed ID: 8913409 [TBL] [Abstract][Full Text] [Related]
29. Glycaemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with type 1 diabetes: meta-analysis of randomised controlled trials. Pickup J; Mattock M; Kerry S BMJ; 2002 Mar; 324(7339):705. PubMed ID: 11909787 [TBL] [Abstract][Full Text] [Related]
30. Switching to multiple daily injection therapy with glulisine improves glycaemic control, vascular damage and treatment satisfaction in basal insulin glargine-injected diabetic patients. Yanagisawa K; Ashihara J; Obara S; Wada N; Takeuchi M; Nishino Y; Maeda S; Ishibashi Y; Yamagishi S Diabetes Metab Res Rev; 2014 Nov; 30(8):693-700. PubMed ID: 24639403 [TBL] [Abstract][Full Text] [Related]
32. Real-time continuous glucose monitoring in adults with type 1 diabetes and impaired hypoglycaemia awareness or severe hypoglycaemia treated with multiple daily insulin injections (HypoDE): a multicentre, randomised controlled trial. Heinemann L; Freckmann G; Ehrmann D; Faber-Heinemann G; Guerra S; Waldenmaier D; Hermanns N Lancet; 2018 Apr; 391(10128):1367-1377. PubMed ID: 29459019 [TBL] [Abstract][Full Text] [Related]
33. Inhaled insulin in diabetes mellitus. Royle P; Waugh N; McAuley L; McIntyre L; Thomas S Cochrane Database Syst Rev; 2003; (3):CD003890. PubMed ID: 12917994 [TBL] [Abstract][Full Text] [Related]
34. [New modes of insulin delivery and new modes of monitoring of type 1 diabetes mellitus]. Renard É Rev Prat; 2018 Jun; 68(6):620-627. PubMed ID: 30869250 [TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro. Lepore M; Pampanelli S; Fanelli C; Porcellati F; Bartocci L; Di Vincenzo A; Cordoni C; Costa E; Brunetti P; Bolli GB Diabetes; 2000 Dec; 49(12):2142-8. PubMed ID: 11118018 [TBL] [Abstract][Full Text] [Related]
39. [Insulin therapy in type 1 diabetes]. Philips JC; Radermecker RP Rev Med Liege; 2005; 60(5-6):322-8. PubMed ID: 16035288 [TBL] [Abstract][Full Text] [Related]
40. Diabetes technology and treatments in the paediatric age group. Shalitin S; Peter Chase H Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]